The first of them, LINC02418, we found overexpressed in the ERG-positive subtype of prostate cancer and, also, differentially expressed between colorectal cancer (CRC) tissues and noncancerous tissues [39] and upregulated in NSCLC (non-small cell lung cancer) tissues [40]. This evidence concerns the gene ERG and non-small cell lung carcinoma.